The biological framework: translational research from bench to clinic

Area of Science:

• Oncology
• Molecular Biology
• Systems Biology

Background:

• Cellular signaling pathways, particularly those involving growth factors and their receptors, are fundamental to cancer research and targeted therapy.
• These pathways regulate tumor development, metastasis, and cell survival under treatment, making them critical therapeutic targets.

Purpose of the Study:

• To explore the complexity of growth factor signaling networks in malignant tumors.
• To investigate novel strategies for disrupting these pathways, including combination therapies and targeting essential network hubs.

Main Methods:

• Review of current research on growth factor signaling in cancer.
• Discussion of engineering and mathematical concepts applied to oncogenic networks.
• Exploration of novel therapeutic approaches like immunotherapy and drug combinations.

Main Results:

• Growth factor signaling pathways are complex and adaptable, often resisting single-agent interventions.
• Multiple perturbations, such as combination therapies, are effective in inhibiting these pathways and inducing tumor cell death.

Conclusions:

• Targeting the intricate growth factor signaling networks in cancer requires sophisticated strategies.
• Novel approaches exploiting pathway vulnerabilities, including combination therapies and immunotherapy, hold significant promise for future cancer treatment.